Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

287
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
287
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

242
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
242
Analgesia and Pain Management01:25

Analgesia and Pain Management

585
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
585
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

761
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
761
Phase I Oxidative Reactions: Overview01:19

Phase I Oxidative Reactions: Overview

268
Phase I biotransformation, or functionalization, is a crucial chemical process that converts drugs and other xenobiotics into more water-soluble forms, facilitating expulsion from the body. It involves oxidative, reductive, and hydrolytic reactions that add or unveil polar functional groups on lipophilic substrates. Key players in phase I reactions are the mixed-function oxidases. Situated in liver cell microsomes, these enzymes predominantly carry out drug metabolism. They require molecular...
268
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems01:19

Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems

191
Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
191

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Unplugged Patient: A Case Report on Bridging the Digital Divide in Palliative Care.

Journal of pain and symptom management·2026
Same author

Routine Urine Drug Screening in Palliative Care - A Call for Evidence Before Implementation.

Journal of pain and symptom management·2026
Same author

Does the Edmonton Symptom Assessment Scale rule in or rule out anxiety and depression?

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same author

A Cross-Sectional Street Survey Examining a Preference for Truth-Telling in Serious Illness and End-of-Life in Maputo City Province.

Journal of palliative medicine·2026
Same author

MASCC score and neutropenic complications: what is the likelihood?

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same author

Intensive nursing intervention: what is the post treatment effect size on anxiety and depression?

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same journal

Screening for substance use disorders in primary care settings: A systematic review.

Journal of opioid management·2026
Same journal

The prevalence of naloxone distribution and training programs at 4-year public colleges in the United States.

Journal of opioid management·2026
Same journal

The effect of a multifaceted intervention on post-operative opioid use after orthopedic and spine surgery: Results of a before-after pilot study.

Journal of opioid management·2026
Same journal

Post-operative opioid consumption after single-shot versus continuous erector spinae plane block in cardiac surgery: An observational study.

Journal of opioid management·2026
Same journal

Outcomes of patients with heart failure with preserved ejection frac-tion on chronic opioids: A nationwide analysis.

Journal of opioid management·2026
Same journal

Barriers providers face to prescribe buprenorphine as MOUD that can inform critical supports after the removal of the DATA-waiver.

Journal of opioid management·2026
See all related articles

Related Experiment Video

Updated: Jun 27, 2025

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
16:02

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation

Published on: February 10, 2023

2.7K

Conversion ratios: Why is it so challenging to construct opioid conversion tables?

Mellar P Davis1, Mary Lynn McPherson2, Akhila Reddy3

  • 1Geisinger Medical Center, Danville, Pennsylvania. ORCID: https://orcid.org/0000-0002-7903-3993.

Journal of Opioid Management
|May 3, 2024
PubMed
Summary
This summary is machine-generated.

Opioid conversion, switching medications to improve pain relief and reduce side effects, is complex. A recently updated equianalgesic table offers practical guidance for palliative care, but more research is needed.

More Related Videos

Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs
10:13

Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs

Published on: November 8, 2024

2.1K
High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

9.6K

Related Experiment Videos

Last Updated: Jun 27, 2025

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
16:02

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation

Published on: February 10, 2023

2.7K
Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs
10:13

Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs

Published on: November 8, 2024

2.1K
High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

9.6K

Area of Science:

  • Pharmacology
  • Pain Management
  • Palliative Care

Background:

  • Standardizing opioid management is difficult due to lack of ceiling dose, unknown therapeutic plasma levels, and unclear dose-response relationships.
  • Opioid rotation or conversion is a common practice, affecting 20-40% of patients, to enhance therapeutic response and mitigate toxicities.
  • Patients often require opioid conversion due to adverse effects, toxicities, or intolerance to specific opioid formulations.

Purpose of the Study:

  • To review 20 years of literature on opioid conversions and discuss the complexities involved.
  • To examine various aspects of opioid conversion, including study designs, outcomes, pain phenotypes, and patient characteristics.
  • To present and discuss a recently updated opioid equianalgesic table for practical use in palliative care.

Main Methods:

  • Systematic review of 20 years of published literature on opioid conversions.
  • Analysis of study designs, outcome measures, pain phenotypes, and patient characteristics.
  • Comparison of opioid equianalgesic doses, conversion ratios, routes, half-lives, metabolites, and interindividual variability.

Main Results:

  • A majority of patients benefit from opioid conversion, experiencing improved analgesia and reduced adverse effects.
  • Various methods for opioid conversion exist in the literature, highlighting the complexity of the process.
  • A recently updated equianalgesic table, based on retrospective evidence, is proposed as a practical tool for palliative care.

Conclusions:

  • Opioid conversion is a complex but often beneficial intervention for improving pain management and reducing toxicity.
  • While palliative care specialists lack consensus on ideal equianalgesic tables, a new table offers practical guidance.
  • Further robust, well-designed studies are essential to validate and refine opioid conversion data and practices.